Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "SEC"

2364 News Found

Akston Biosciences and Biolexis partner to develop second-gen COVID-19 vaccine
News | March 19, 2022

Akston Biosciences and Biolexis partner to develop second-gen COVID-19 vaccine

Biolexis will also leverage the capabilities of Strides Group for launching this vaccine across regions where the group has a deep market presence and established relationships


Department of Pharmaceuticals release code to regulate medical devices sector
News | March 17, 2022

Department of Pharmaceuticals release code to regulate medical devices sector

If the government feels that the industry is not complying with the uniform code, it will consider making it a statutory code


Boston Scientific opens second R&D centre in Pune
News | March 16, 2022

Boston Scientific opens second R&D centre in Pune

The centre will initially employ 170 engineers, bringing the total number of Boston Scientific’s R&D employees in India to more than 300


Japan tops CPhI ‘API Quality’ ranking for second year
News | March 13, 2022

Japan tops CPhI ‘API Quality’ ranking for second year

Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers


Alvotech settles with AbbVie to secure US rights to Humira biosimilar
Biotech | March 09, 2022

Alvotech settles with AbbVie to secure US rights to Humira biosimilar

Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023


Industry upbeat on biopharma sector
News | March 08, 2022

Industry upbeat on biopharma sector

Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector


Merck’s KEYTRUDA demonstrates extended relief for patients with resected stage IIB and IIC melanoma
Biotech | March 08, 2022

Merck’s KEYTRUDA demonstrates extended relief for patients with resected stage IIB and IIC melanoma

New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients


Govt announces over Rs 100 crore investment for Ayush sector in Nagaland
Public Health | March 04, 2022

Govt announces over Rs 100 crore investment for Ayush sector in Nagaland

Ten new Ayush hospitals and one Ayurvedic college will be set up in Nagaland and Mizoram


Cipla gets approval from SEC to conduct Paxlovid trials
News | March 03, 2022

Cipla gets approval from SEC to conduct Paxlovid trials

Paxlovid consists of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and ritonavir, which slows down nirmatrelvir’s breakdown to help it remain in the body for a longer period at higher concentrations


Telangana draws Rs 6,400 crore  investment in pharma sector in 2021 : KT Rama Rao
Biotech | February 24, 2022

Telangana draws Rs 6,400 crore investment in pharma sector in 2021 : KT Rama Rao

The Genome Valley region has played a pivotal role in fostering the life science industry and the state government has always supported its growth